KYORIN Holdings, Inc.
TSE:4569.T
Overview | Financials
Company Name | KYORIN Holdings, Inc. |
Symbol | 4569.T |
Currency | JPY |
Price | 1,475 |
Market Cap | 84,736,662,875 |
Dividend Yield | 3.01% |
52-week-range | 1,468 - 1,880 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yutaka Ogihara |
Website | https://www.kyorin-gr.co.jp |
An error occurred while fetching data.
About KYORIN Holdings, Inc.
KYORIN Holdings, Inc., through its subsidiaries, researches and develops, produces, and sells ethical and generic drugs in Japan and internationally. The company offers Flutiform, a drug for the treatment of asthma; Desalex, an antiallergic agent; Beova, Uritos, and Imidafenacin KYORIN therapeutic agents for overactive bladder; Lasvic, a quinolone synthetic antibacterial
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD